Skip to main content
Clinical Trials/NCT06293807
NCT06293807CompletedEarly Phase 1

Immediate Post-Operative Anesthesia With Either Lidocaine or Bupivacaine: A Short-term Clinical Response

The University of Texas Health Science Center at San Antonio1 site in 1 country72 target enrollmentStarted: June 6, 2022Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Early Phase 1
Status
Completed
Enrollment
72
Locations
1
Primary Endpoint
Number of Ibuprofen administered

Study Overview

Brief Summary

Immediate post-suturing administration of either one of two dental anesthetic solutions or a placebo prior to dismissal.

Detailed Description

This study seeks to evaluate the pain response following the administration of two anesthetic solutions just prior to patient dismissal from a surgical procedure: 2% Xylocaine with 1:100,000 epi and 0.5% Bupivicaine with 1:200,000 epi in comparison with 0.9% Normal Saline as a placebo. the study team will monitor pain response following these interventions at 4, 8, 12, 24, and 48 hours.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Masking Description

Both the surgeon and patient will be blinded as to the intervention provided by covering identifying marks of the anesthetic carpules to be administered. Randomization will be assured by random selection of a slip of paper drawn from a sealed envelope assigning the patient to one of three groups.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients who have undergone a comprehensive periodontal evaluation and treatment plan not related to participation in this study and...
  • require flap surgery of 2 to 5 teeth in a continuous site (including flap debridement, flap osseous, extractions, and Guided Tissue Regeneration (GTR) procedures), and...
  • require IV sedation and local anesthesia or local anesthesia only...
  • in either the maxillary or mandibular arch.

Exclusion Criteria

  • Pregnancy, or those planning to become pregnant
  • allergy or any medical issue using Lidocaine or Bupivacaine
  • inability to take non-steroidal anti-inflammatory drugs (NSAIDS) or acetaminophen
  • non-English speaking
  • not possessing an I-phone or Android device
  • patients requiring narcotic for IV sedation
  • patients requiring either IV or oral steroids during the perioperative period

Arms & Interventions

Placebo control group

Placebo Comparator

Participants have been scheduled to receive an area of gum surgery to treat periodontal (gum) disease in their mouth while under intravenous (IV) conscious sedation. The study drug is administered after surgery.

Intervention: Placebo (Other)

Outcomes

Primary Outcomes

Number of Ibuprofen administered

Time Frame: Baseline to 48 hours

Additive number of ibuprofen taken over monitoring period

Change in pain using Visual Analog Scale (VAS)

Time Frame: Baseline to 48 hours

Pain response recorded using a 20 point visual Analog Scale. The VAS scale is a straight line scale scored from 0-20 with 0 indicating the least amount of pain and 20 the worst pain ever experienced.

Number of Tylenol administered

Time Frame: Baseline to 48 hours

Additive number of acetaminophen taken over monitoring period

Secondary Outcomes

  • Type of procedure(Baseline to 48 hours)
  • Arch Response(Baseline to 48 hours)
  • Number of teeth(Baseline to 48 hours)
  • Gender of patient(Baseline to 48 hours)
  • Age of patient(Baseline to 48 hours)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Immediate Post-Operative Anesthesia With... | Clinical Trial